Congenital Malformations
8
1
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Contribution of Optical Genome Mapping (OGM) in the Diagnosis of Multiple Congenital Malformations With or Without Intellectual Disability Without Genetic Abnormality
Maternal Use of Antibiotics and the Risk of Congenital Malformations
Perinatal Conditions Influencing Morbidity, Mortality, and Medical Care in Newborns
Fast Exome for Diagnosis of Congenital Conditions in Infants Under 12 Months of Age Hospitalized in Intensive Care Unit
Irradiated Blood Versus Non Irradiated Blood Transfusions in Craniosynostosis Repair
Lethal Congenital Malformations: Palliative Therapy From An Islamic Point of View
Folic Acid Dosage and Malformations Reduction
Autologous Fat Grafting to the Breast